(CNN) — Johnson & Johnson, the world’s largest health products company, is splitting up. The company, which traces its roots back to 1886, will break into two: One company will focus on consumer ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

A Price to Earnings ratio of 21.79 significantly below the industry average by 0.28x suggests undervaluation. This can make the stock appealing for those seeking growth. Considering a Price to Book ...

In the latest trading session, Johnson & Johnson (JNJ) closed at $228.17, marking a +2.21% move from the previous day. This change outpaced the S&P 500's 0.41% gain on the day. At the same time, the ...

At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients ...

Racking up a five-bagger investment -- when one of your holdings grows by 5x -- is quite the accomplishment, and finding potential five-baggers is a great way to set your portfolio up for success.

CHARLESTON, W.Va. (AP) - West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen Pharmaceuticals Inc. over the drugmaker's role in ...

Johnson & Johnson reported mediocre results for fiscal 2022, but is expecting low-to-mid single digit growth for fiscal 2023. The company is facing a patent cliff and might have trouble in the next ...